Should Aveo Run Second Study of Kidney Cancer Drug, FDA Asks

An FDA advisory panel will be reviewing tivozanib on Thursday. Frankly, I'm surprised at the ferocity of selling in Aveo this morning.

http://www.thestreet.com/story/11909243/1/should-aveo-run-second-study-of-kidney-cancer-drug-fda-asks.html